Evidence map›Paper›PMID 35295707›Full record

ArticleFrontiers in molecular neuroscience2022

Quercetin Mitigates Methamphetamine-Induced Anxiety-Like Behavior Through Ameliorating Mitochondrial Dysfunction and Neuroinflammation.

Fengrong Chen, Jiaxue Sun, Cheng Chen, Yongjin Zhang, Lei Zou, Zunyue Zhang, Minghui Chen, Hongjin Wu, Weiwei Tian, Yu Liu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Anxiety and Metabolic Disorders: The Role of Botanicals.Current issues in molecular biology · 2023
    Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Fengrong ChenSchool of Medicine, Kunming University of Science and Technology, Kunming, China.
Jiaxue SunNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Cheng ChenNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Yongjin ZhangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Lei ZouNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Zunyue ZhangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Minghui ChenSchool of Medicine, Kunming University of Science and Technology, Kunming, China.
Hongjin WuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Weiwei TianNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Yu LiuThe School of Foreign Languages, University of Shanghai for Science and Technology, Shanghai, China.
Yu XuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Huayou LuoNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Mei ZhuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Juehua YuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Qian WangTianhua College, Shanghai Normal University, Shanghai, China.
Kunhua WangNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, China.
Kunming Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CNShanghai Normal University · CNUniversity of Shanghai for Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methamphetamine (MA) abuse results in neurotoxic outcomes, including increased anxiety and depression. Studies have reported an association between MA exposure and anxiety, nonetheless, the underlying mechanism remains elusive. In the present study, we developed a mouse model of anxiety-like behavior induced by MA administration. RNA-seq was then performed to profile the gene expression patterns of hippocampus (HIPP), and the differentially expressed genes (DEGs) were significantly enriched in signaling pathways related to psychiatric disorders and mitochondrial function. Based on these, mitochondria was hypothesized to be involved in MA-induced anxiety. Quercetin, as a mitochondrial protector, was used to investigate whether to be a potential treatment for MA-induced anxiety; accordingly, it alleviated anxiety-like behavior and improved mitochondrial impairment

Indexed as

anxietymethamphetaminemitochondrial dysfunctionneuroinflammationoxidative stressquercetin

Identifiers

PMID35295707
PMCPMC8919775
OpenAlexW4221086241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.